0000000000283211

AUTHOR

Teresa Vezza

0000-0002-9780-0180

showing 7 related works from this author

PGK1-AR axis: Benefits of a novel actor in PCOS pathology.

2020

lcsh:R5-920business.industrylcsh:RMEDLINElcsh:MedicineGeneral MedicineBioinformaticsGeneral Biochemistry Genetics and Molecular BiologyPhosphoglycerate KinaseText miningReceptors AndrogenCommentaryMedicineHumansFemaleDisease Susceptibilitybusinesslcsh:Medicine (General)Polycystic Ovary SyndromeSignal TransductionEBioMedicine
researchProduct

Does Empagliflozin Modulate Leukocyte–Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?

2021

Sodium-glucose co-transporter 2 inhibitors (iSGLT2) have been linked to cardiovascular risk reduction in patients with type 2 diabetes (T2D). However, their underlying molecular mechanisms remain unclear. This study aimed to evaluate the effects of empagliflozin, a novel potent and selective iSGLT-2, on anthropometric and endocrine parameters, leukocyte–endothelium interactions, adhesion molecules, ROS production, and NFkB-p65 transcription factor expression. According to standard clinical protocols, sixteen T2D patients receiving 10 mg/day of empagliflozin were followed-up for 24 weeks. Anthropometric and analytical measurements were performed at baseline, 12 weeks, and 24 weeks. Interacti…

Mitochondrial ROScardiovascular riskGPX1medicine.medical_specialtyEndotheliumPhysiologyClinical Biochemistryempagliflozin030209 endocrinology & metabolismLeukocyte RollingInflammationRM1-950030204 cardiovascular system & hematologymedicine.disease_causeBiochemistry03 medical and health sciences0302 clinical medicineInternal medicineEmpagliflozinmedicineoxidative stressMolecular Biologybusiness.industryCell adhesion moleculeCommunicationCell Biologymedicine.anatomical_structureEndocrinologyinflammationtype 2 diabetesTherapeutics. Pharmacologymedicine.symptombusinessOxidative stressAntioxidants
researchProduct

Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes

2020

The rising prevalence of obesity and type 2 diabetes (T2D) is a growing concern worldwide. New discoveries in the field of metagenomics and clinical research have revealed that the gut microbiota plays a key role in these metabolic disorders. The mechanisms regulating microbiota composition are multifactorial and include resistance to stress, presence of pathogens, diet, cultural habits and general health conditions. Recent evidence has shed light on the influence of microbiota quality and diversity on mitochondrial functions. Of note, the gut microbiota has been shown to regulate crucial transcription factors, coactivators, as well as enzymes implicated in mitochondrial biogenesis and meta…

0301 basic medicineobesitymitochondrial oxidative/nitrosative stressPhysiologyClinical BiochemistryInflammationReviewType 2 diabetesMitochondrionGut floraBioinformaticsdigestive systemBiochemistryProinflammatory cytokine03 medical and health sciences0302 clinical medicinemedicineMolecular BiologyTranscription factorgut microbiotabiologylcsh:RM1-950InflammasomeCell Biologybiology.organism_classificationmedicine.diseasemitochondrialcsh:Therapeutics. Pharmacology030104 developmental biologyMitochondrial biogenesisinflammation030220 oncology & carcinogenesistype 2 diabetesmedicine.symptommedicine.drugAntioxidants
researchProduct

MicroRNAs and Oxidative Stress: An Intriguing Crosstalk to Be Exploited in the Management of Type 2 Diabetes

2021

Type 2 diabetes is a chronic disease widespread throughout the world, with significant human, social, and economic costs. Its multifactorial etiology leads to persistent hyperglycemia, impaired carbohydrate and fat metabolism, chronic inflammation, and defects in insulin secretion or insulin action, or both. Emerging evidence reveals that oxidative stress has a critical role in the development of type 2 diabetes. Overproduction of reactive oxygen species can promote an imbalance between the production and neutralization of antioxidant defence systems, thus favoring lipid accumulation, cellular stress, and the activation of cytosolic signaling pathways, and inducing β-cell dysfunction, insul…

0301 basic medicinePhysiologymedicine.medical_treatmentClinical BiochemistryInflammationRM1-950Type 2 diabetesReviewBiologymedicine.disease_causeBiochemistry03 medical and health sciences0302 clinical medicineInsulin resistancemicroRNAmedicineoxidative stressredox signalingMolecular BiologymicroRNAInsulinCell Biologymedicine.diseaseCell biologyCrosstalk (biology)030104 developmental biology030220 oncology & carcinogenesisTherapeutics. Pharmacologytype 2 diabetesmedicine.symptomSignal transductionOxidative stressAntioxidants
researchProduct

The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice

2018

The beneficial effects of probiotics on immune-based pathologies such as inflammatory bowel disease (IBD) have been well reported. However, their exact mechanisms have not been fully elucidated. Few studies have focused on the impact of probiotics on the composition of the colonic microbiota. The aim of the present study was to correlate the intestinal anti-inflammatory activity of the probiotic Escherichia coli Nissle 1917 (EcN) in the dextran sodium sulfate (DSS) model of mouse colitis with the changes induced in colonic microbiota populations. EcN prevented the DSSinduced colonic damage, as evidenced by lower disease activity index (DAI) values and colonic weight/length ratio, when compa…

intestinal microbiota0301 basic medicineDSS colitisIntestinal microbiotaProbioticmedicine.disease_causeInflammatory bowel diseaselaw.invention03 medical and health sciencesProbioticImmune systemlawmicroRNAmedicinePharmacology (medical)ColitisEscherichia coliOriginal ResearchPharmacologymicroRNAbusiness.industrylcsh:RM1-950PyrosequencingMicroRNAmedicine.diseasepyrosequencinglcsh:Therapeutics. Pharmacology030104 developmental biologyMechanism of actionImmunologymedicine.symptombusinessDysbiosisprobioticFrontiers in Pharmacology
researchProduct

Phytosterols: Nutritional Health Players in the Management of Obesity and Its Related Disorders

2020

Obesity and its related disorders, such as diabetes and cardiovascular risk, represent an emerging global health issue. Even though genetic factors seem to be the primary actors in the development and progression of these diseases, dietary choices also appear to be of crucial importance. A healthy diet combined with physical activity have been shown to ameliorate glycaemic levels and insulin sensitivity, reduce body weight and the risk of chronic diseases, and contribute to an overall improvement in quality of life. Among nutrients, phytosterols have become the focus of growing attention as novel functional foods in the management of metabolic disorders. Phytosterols are natural plant compo…

0301 basic medicineobesityPhysiologyClinical Biochemistryphytosterols030209 endocrinology & metabolismReviewBioinformaticsBiochemistryManagement of obesity03 medical and health scienceschemistry.chemical_compound0302 clinical medicineQuality of life (healthcare)Immune systemDiabetes mellitusGlobal healthmicrobiotaMedicinemetabolic disordersMolecular Biologybioactive compoundsbusiness.industryCholesterollcsh:RM1-950Insulin sensitivityCell Biologymedicine.diseaseObesityantioxidant properties030104 developmental biologylcsh:Therapeutics. Pharmacologychemistryanti-inflammatory propertiesbusinessAntioxidants
researchProduct

The HIF1α-PFKFB3 Pathway: A Key Player in Diabetic Retinopathy

2021

Abstract Diabetic retinopathy (DR) is the leading cause of blindness for adults in developed countries. Both microvasculopathy and neurodegeneration are implicated in mechanisms of DR development, with neuronal impairment preceding microvascular abnormalities, which is often underappreciated in the clinic. Most current therapeutic strategies, including anti-vascular endothelial growth factor (anti-VEGF)-antibodies, aim at treating the advanced stages (diabetic macular edema and proliferative diabetic retinopathy) and fail to target the neuronal deterioration. Hence, new therapeutic approach(es) intended to address both vascular and neuronal impairment are urgently needed. The hypoxia-induci…

medicine.medical_specialtyPhosphofructokinase-2Endocrinology Diabetes and MetabolismClinical BiochemistryMitochondrionmedicine.disease_causeBiochemistryangiogenesisEndocrinologyPFKFB3Internal medicineDiabetes MellitusmedicineHumansHIF1αbusiness.industryBiochemistry (medical)neurodegenerationDiabetic retinopathyMini-Reviewmedicine.diseasediabetic retinopathyEndocrinologyKey (cryptography)businessAcademicSubjects/MED00250Oxidative stressSignal TransductionThe Journal of Clinical Endocrinology & Metabolism
researchProduct